eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
1/2020
vol. 45
 
Share:
Send email
Share:
abstract:
Short communication

Biclonal myeloma in renal failure

Milena K. Nikolova-Vlahova
1
,
Miroslava Kamburova
2
,
Julieta Hristova
2
,
Dimitrios Vasileiou
2
,
Boris Bogov
2
,
Rumiana Krasteva
2
,
Evgeni Hadjiev
2
,
Gergana Tsvetkova
2
,
Cvetelina Vasileva
2
,
Nikolai Houbanov
2

  1. University Hospital St. Ivan Rilski, Sofia, Bulgaria
  2. University Hospital Alexandrovska, Sofia, Bulgaria
(Centr Eur J Immunol 2020; 45 (1): 122-124)
DOI: https://doi.org/10.5114/ceji.2020.94714
Online publish date: 2020/04/06
View full text Get citation
 
PlumX metrics:
Multiple myeloma is a clonal proliferation of the plasma cell line that accounts for approximately 10% of all hematological malignancies. It is characterized by abnormal growth of plasma cells producing monoclonal immunoglobulin or light chain (paraprotein), with subsequent development of osteolytic bone lesions, anemia, hypercalcemia, and renal failure. In 3-6% of myeloma patients, more than one monoclonal protein (usually two) is discovered, with different heavy or light chain or both. These additional monoclonal proteins may be identified at the time of diagnosis or appear later during an observation or therapy. The authors describe two patients with biclonal myeloma, one diagnosed during evaluation for newly discovered renal failure, and one identified in the course of treatment

of monoclonal gammopathy. The discussion of the diagnosis, natural history, and prognosis in patients with biclonal myeloma are also reported.
keywords:

myeloma, biclonal, renal failure, diagnosis, natural history, management
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.